Journal · Updated 2026-08-11

GLP-1s in Montana (2026): Who Ships Here, the Two License Checks, and Current Prices

By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify

The two licenses, and where Montana keeps the records

Telehealth GLP-1 care has two regulated ends, and Montana lets you check both in minutes. The clinician who evaluates you must be licensed in Montana at the time of the visit — national platforms satisfy this by routing you to their Montana-licensed prescribers, verifiable on the state's medical and nursing board lookups. The pharmacy that ships your medication must hold a Montana license; for the out-of-state 503A compounders that fill most of this market, that means a non-resident pharmacy license, searchable by name on the Montana Board of Pharmacy's lookup along with any disciplinary history. Run it for whichever pharmacy your program names — NexLife's disclosed network (Absolute, Hallandale, Red Rock, Empower, Strive) checks name by name — and treat a program that won't name its pharmacy as having failed the check by default.

Availability and the local exceptions

Per our records, with statuses attached: the brand-direct channels are unrestricted here, Henry Meds publishes Montana inside its footprint (its nine exclusions are AL, AK, AR, HI, LA, MS, MO, SC and WV), and the broad-availability programs — NexLife, bmiMD, HealthRX, Yucca, OrderlyMeds, Ivim, Found, ShedRx, TMates, Gala and the rest — carry "confirm your state at intake" on our rows precisely because licensure footprints move. Mochi Health's reported ten-state footprint (mid-2026: AZ, CO, FL, GA, IL, MA, MD, MN, NY, OR) does not include Montana — its closest structural neighbors here are Ivim's membership model and the flat-rate no-membership programs. Every availability claim on this page carries the capture-date caveat, and the intake screen is the final authority.

Prices and the Montana decision path

Run it in this order. Insurance first: a covered commercial patient at a twenty-five-dollar copay — or a qualifying Medicare beneficiary at fifty via the July 2026 GLP-1 bridge — beats every cash figure below, and the insurance path guide applies in Montana verbatim. Cash second: the cheapest month-to-month figures serving Montana are bmiMD's one twenty-nine for semaglutide and NexLife's one sixty-nine promotional for tirzepatide, the committed floors are ninety-nine and one twenty-five to one thirty-nine, and the FDA-approved benchmarks are oral Wegovy from one forty-nine, the pen at three forty-nine, and Zepbound vials at two ninety-nine to four forty-nine under the 45-day rule. Verification third: the two license lookups above on whatever you choose, plus the fifteen-minute pharmacy vetting process. That order — coverage, cash, checks — is the whole method, in this state and every state.

Does Montana Medicaid cover GLP-1s for weight loss?

Montana does not cover GLP-1s for weight loss under Medicaid as of the 2026 verifications — the position of most states, covering roughly four in five adult enrollees nationally. A coverage bill (SB 417) did not advance.

Whatever the weight-loss answer, the structural doors hold here as everywhere: every state Medicaid program covers GLP-1s for type 2 diabetes, the non-weight indication doors — cardiovascular risk reduction, obstructive sleep apnea, kidney disease, MASH — generally must be covered with prior authorization under federal rebate-program rules (the indication-door playbook maps each one), and enrollees under twenty-one keep the federal EPSDT medical-necessity path. National picture and every dated change: the Medicaid hub and the 2026 change ledger; coverage lists move through budget sessions, so re-verify annually with the state program or your managed-care plan.

This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.